Founded in 2021, DMBIO has continuously grown as an innovative company in the medical and beauty industries, specializing in dermatology, human tissue–based medical devices, and cosmeceutical product development.

By collaborating with partners worldwide, we deliver products of superior quality and high safety standards, while pursuing continuous research and challenges to lead the rapidly evolving medical aesthetics market.

DMBIO aspires to become a leader shaping a new paradigm in the global market, creating sustainable value and driving meaningful change in the industry and society.